Sildenafil 100 mg 20 tablets
Semax nasal drops 0.1% 3 ml
Prednisolone 5mg 100 tablets
Tamiflu 75 mg 10 capsules
Plaquenil 200 mg 60 tablets
Champix 1 mg 112 tablets
Ingavirin 90 mg 10 capsues
Ovestin 2 mg 30 tablets
Ovestin Vaginal cream 15g
Macmiror 200 mg 20 tablets
Ventolin nebula 20 ampoules
- Antibacterial medication
- Antifungal medication
- Antiviral Medication
- Cardiovascular medication
- different medication
- Hormonal medication
- Immunosuppressants and immunomodulating medications
- Nervous system
- Pain relievers and anti-inflammatory
- Respiratory system
- Treatment of diseases of the liver and gastrointestinal tract
- Treatment of sensory organs, eyesight and hearing
- Urogenital system
De-Nol 120mg 112 tablets
De-Nol 120mg 56 tablets
De-Nol 120mg 32 tablets
finasteride 5mg 30 tablets
Itrazole 100 mg 42 capsules
furasol 15 sachets of 100 mg
Triacort OINTMENT 0.1% 10G
Urseptia 200 mg 20 capsules
Minolexin 100 mg 20 capsules
Minolexin 50 mg 20 capsules
Immard 200 mg 30 tablets
Adenuric 120 mg 28 tablets
Picamilon 20 mg 30 tablets
Zonegran 25 mg 14 tablets
Mexidol 5 ml 5 vials
Biloba 40 mg 60 capsules
Phezam 400/25 mg 60 Capsules
Ginos 40 mg 30 tablets
Mydocalm 150 mg 30 tablets
Actovegin 2 ml 25 vials
betaserc 24 mg 20 tablets
Vasobral 30 tablets
Axamon 20 mg 50 tablets
Fezam 60 Capsules
Vinpocetine 5 mg 50 tablets
Stugeron 25mg 50 tablets
Pantogam 250 mg 50 tablets
Lamolep 50 mg 30 tablets
Mydocalm 1 ml 5 vials
Melaxen 3 mg 12 tablets
tagista 16 mg 30 tablets
Teraligen 5 mg 25 tablets
Trileptal 150 mg 50 tablets
Mydocalm 50 mg 30 tablets
Dobrokam 250 mg 30 tablets
Ceraxon 500 mg/4 ml 5 vials
Valtrex 500 mg 10 tablets
Manufacturer: GlaxoSmithKline
Country of origin: Spain / Poland
General description: Antiviral drug
pharmachologic effect
Valacyclovir is an antiviral agent, it is an L-valine ester of acyclovir. Acyclovir is an analogue of a purine nucleoside (guanine).
In the human body, valaciclovir is rapidly and almost completely converted into acyclovir and valine, presumably under the influence of the enzyme valacyclovirhydrolase.
Acyclovir is a specific inhibitor of herpes viruses with in vitro activity against Herpes simplex virus types 1 and 2, Varicella zoster virus, Varicella zoster, cytomegalovirus (CMV), Epstein-Barr virus (VEB) and virus herpes simplex type 6. Acyclovir inhibits the synthesis of viral DNA immediately after phosphorylation and conversion into an active form - acyclovir triphosphate.
The first stage of phosphorylation requires the activity of virus-specific enzymes. For HSV, VZV and VEB, this enzyme is viral thymidine kinase, which is present only in the cells infected with the virus. Partially, the selectivity of phosphorylation is maintained in the cytomegalovirus indirectly through the product of the phosphotransferase UL97 gene. This need to activate acyclovir with a specific viral enzyme largely explains its selectivity. The process of phosphorylation of acyclovir (conversion from mono- to triphosphate) is completed by cellular kinases.
Acyclovir triphosphate competitively inhibits viral DNA polymerase and, being an analogue of a nucleoside, is inserted
into viral DNA, which leads to an obligate rupture of the chain, stopping the synthesis of DNA and, consequently, to blocking the replication of the virus.
Resistance to acyclovir is usually due to a deficiency of thymidine kinase, which leads to an excessive spread of the virus in the host. In rare cases, a decrease in sensitivity to acyclovir is due to the appearance of strains of the virus with a violation of the structure of viral thymidine kinase or DNA polymerase. The virulence of these varieties of the virus resembles that of its wild strain.
Based on the results of an extensive study of HSV and VZV strains selected from patients treated with acyclovir or used for prevention, it was found that viruses with reduced sensitivity to valacyclovir are extremely rare, but can be detected in rare cases in patients with severe immunity, for example, bone marrow transplant recipients or organ, patients receiving chemotherapy for malignant neoplasms, and in HIV-infected patients.
Valaciclovir contributes to the relief of pain syndrome: reduces its duration and reduces the percentage of patients with pain caused by herpes zoster, including acute postherpetic neuralgia.
Indications
Adults and adolescents aged 12 to 18 years
- treatment of infections of the skin and mucous membranes caused by HSV, including the newly identified and recurring genital herpes (Herpes genitalis), as well as the labial herpes (Herpes labialis);
- prevention (suppression) of recurrences of infections of the skin and mucous membranes caused by HSV, including genital herpes, incl. in adults with immunodeficiency;
- Prevention of infections caused by cytomegalovirus (CMV), and
diseases after transplantation of parenchymal organs.
Adults
- Treatment of herpes zoster (Herpes zoster) and ophthalmic herpes zoster.


.